(MedPage Today) — CHICAGO — The WARRIOR trial was not able to prove that intensive medical therapy reduced major adverse cardiovascular events (MACE) in women with ischemia but no obstructive disease. For symptomatic patients with suspected… Source link : https://www.medpagetoday.com/meetingcoverage/acc/114886 Author : Publish date : 2025-03-29 21:34:00 Copyright for syndicated content belongs to the linked […]
The post Benefit for Women’s INOCA Eludes Familar Cardiovascular Meds in WARRIOR first appeared on News Health.
Author : News Health
Publish date : 2025-03-29 21:34:00
Copyright for syndicated content belongs to the linked Source.